Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exosomes | 2 | 2023 | 424 | 0.720 |
Why?
|
| Bacteriophages | 1 | 2022 | 378 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2022 | 988 | 0.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2024 | 2898 | 0.290 |
Why?
|
| Lymphoma, B-Cell | 3 | 2022 | 940 | 0.260 |
Why?
|
| Peptides | 4 | 2023 | 4358 | 0.240 |
Why?
|
| MicroRNAs | 4 | 2023 | 3816 | 0.220 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2022 | 13 | 0.220 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2022 | 64 | 0.210 |
Why?
|
| Peptide Library | 2 | 2021 | 347 | 0.210 |
Why?
|
| Drug Discovery | 2 | 2021 | 1051 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2024 | 1076 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 1136 | 0.160 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2020 | 1640 | 0.150 |
Why?
|
| B-Lymphocytes | 3 | 2020 | 4758 | 0.150 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 337 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2022 | 1007 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2020 | 545 | 0.140 |
Why?
|
| Myxoma | 1 | 2017 | 114 | 0.140 |
Why?
|
| Multiple Myeloma | 2 | 2024 | 5146 | 0.130 |
Why?
|
| Rhinitis | 1 | 2022 | 747 | 0.120 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 362 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1626 | 0.110 |
Why?
|
| Sinusitis | 1 | 2022 | 991 | 0.110 |
Why?
|
| Epitopes | 1 | 2019 | 2503 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1745 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 946 | 0.090 |
Why?
|
| Lymphoma | 1 | 2020 | 1901 | 0.090 |
Why?
|
| Antineoplastic Agents | 3 | 2024 | 13642 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 5305 | 0.080 |
Why?
|
| Macrophages | 3 | 2018 | 5767 | 0.080 |
Why?
|
| Meningioma | 1 | 2017 | 1218 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2017 | 3066 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 1248 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2020 | 5112 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3878 | 0.070 |
Why?
|
| Cell Count | 2 | 2017 | 1835 | 0.050 |
Why?
|
| Calreticulin | 1 | 2024 | 114 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 16990 | 0.050 |
Why?
|
| Peptides, Cyclic | 1 | 2023 | 392 | 0.050 |
Why?
|
| Mice | 6 | 2024 | 81539 | 0.050 |
Why?
|
| Mast Cells | 2 | 2017 | 1392 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2022 | 451 | 0.040 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2019 | 28 | 0.040 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2020 | 99 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9280 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2020 | 662 | 0.040 |
Why?
|
| Animals | 7 | 2024 | 168475 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 718 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2017 | 235 | 0.030 |
Why?
|
| beta Catenin | 1 | 2022 | 1040 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9032 | 0.030 |
Why?
|
| Autophagy | 1 | 2024 | 1327 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10451 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 657 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2023 | 8554 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1321 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2019 | 1880 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2018 | 553 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1869 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 636 | 0.030 |
Why?
|
| Humans | 14 | 2024 | 761596 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3272 | 0.030 |
Why?
|
| Apoptosis | 2 | 2020 | 9490 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4281 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22173 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2961 | 0.020 |
Why?
|
| Cell Survival | 1 | 2020 | 5791 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8633 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 2645 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5439 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6534 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10766 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9542 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2811 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2022 | 18966 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8466 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11076 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10774 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13367 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13510 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18255 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23447 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29629 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 169310 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 220921 | 0.010 |
Why?
|
| Adult | 2 | 2017 | 221210 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 80647 | 0.000 |
Why?
|
| Male | 1 | 2017 | 360846 | 0.000 |
Why?
|
| Female | 1 | 2017 | 392705 | 0.000 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_